Biogen Idec (NASDAQ:BIIB)

automatic inspection machine

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

Almost every asset class is overbought now, and the few that aren’t — with the exception of one — have good reasons. Utilities and other income proxy stocks that were big in ...
Read Full Story »
Wow

Major Biotechs Scare Off Loads of Short Sellers

The short interest data are out for the most recent settlement date, January 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Best Buy, Caterpillar, Nokia, UnitedHealth, Wal-Mart and Many More

Stocks were indicated higher on Tuesday, and the Dow is now up over 20,000 again. Even though the bull market is nearing eight years old, investors keep finding new reasons to ...
Read Full Story »
biotech word cloud

Short Sellers Back Off Major Biotechs

The short interest data are out for the most recent settlement date, January 13. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with ...
Read Full Story »
Good heart health

What to Expect From Major Health Care Stocks Reporting This Week

As January comes to a close, we are in the heart of earnings season, when most companies report and set a direction for the market. Dow 20,000 has been reached but ...
Read Full Story »
Female patient on gurney

Tuesday’s Top Biopharma Movers

Some biotech and pharma companies were on the move Tuesday. A few of the smaller caps made tremendous gains on the day, as the fourth-quarter earnings season is kicking off. ...
Read Full Story »
research

Biotech Short Sellers Run for Cover

The short interest data are out for the most recent settlement date, December 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Biogen, Comerica, Deere, NVIDIA, 21st Century Fox and More

The march to the Dow Jones Industrial Average 20,000 level took a hit yesterday as the venerable index had just its second triple-digit down day in the past two months, ...
Read Full Story »
biotech word cloud

Biotech Short Interest Sinks

The short interest data are out for the most recent settlement date, December 15. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
buy sell

Top Analysts Upgrades and Downgrades: Biogen, FedEx, Lions Gate, Rexnord, Ionis Pharmaceutical and More

With just one trading week left for 2016, and a shortened one at that due to the market holiday yesterday, investors will be making some final changes, perhaps doing some ...
Read Full Story »
choose happiness

RBC Likes Large Cap Biotech Leaders for 2017

After a very poor 2016 for the biotechs, some on Wall Street are beginning to think that the light at the end of the tunnel may not be another train ...
Read Full Story »
approve disapprove

Top Analysts Upgrades and Downgrades: Apple, Biogen, FedEx, GE, Las Vegas Sands and More

After a down day when the Federal Reserve raised interest rates on Wednesday, the market rallied again yesterday, although it closed well off the morning highs. It appears the rally ...
Read Full Story »
biotech word cloud

Biotech Short Interest Remains Mixed

The short interest data are out for the most recent settlement date, November 30. Generally speaking, companies within the biotech industry are considered to have a riskier group of stocks, ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Alliance Data, Autodesk, Biogen, Broadcom, Delta Air Lines, Finisar and More

After another record day for the markets yesterday, the futures are pointing once again to a higher open, and this week looks poised to go down as yet another winner ...
Read Full Story »
biotech word cloud

Short Sellers Grow More Aggressive on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »